Fig. 1
From: MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
Expression of miR-128 in human breast cancer specimens and cell lines. a Comparison of the miR-128 abundance in 33 paired clinical cases. The miR-128 expression levels of adjacent normal tissues and cancer specimens, normalized to the internal control U6, are displayed in moderate-blue and -pink dots, respectively. b Comparison of the miR-128 abundance in breast cancer specimens with grade II and III. The miR-128 expression levels of breast cancer specimens with grade II (n = 14) and III (n = 19), normalized to the adjacent normal tissues, are displayed in dark-cyan and -yellow dots, respectively. c Difference of miR-128 in MCF7 and other six breast cancer cell lines. The expression levels of miR-128 in BT-474, MDA-MB-468, HCC1937, MDA-MB-231, BT549 and MDA-MB-435 s are normalized to MCF7, a lowest aggressive breast cancer cell line. The symbol *, ** and *** represent P < 0.05, P < 0.01 and P < 0.001, respectively, using a two-tailed Student’s t-test